Pediatric Mycoplasma pneumoniae-induced rash and mucositis in China: clinical spectrum, co-infections and risk factors for recurrence—a retrospective cohort study
Open Access
- 1 October 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 6, 1646688
Abstract
Background: Mycoplasma pneumoniae–induced rash and mucositis (MIRM) is a unique entity distinct from both erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. There are limited data on pediatric cases of MIRM in China.Objective: To evaluate the clinical characteristics and recurrence frequency of pediatric cases of MIRM and to summarize the co-infections beyond M. pneumoniae infection.Methods: This retrospective study was conducted through a chart review of patients with MIRM admitted to dermatology inpatient department from September 2017 to July 2021. Pediatric patients with MIRM 4 years to 12 years who met Canavan's criteria were included in the study.Results: A total of 23 patients with MIRM aged 7.86 ± 2.92 years were included. Oral mucosa was the most common site of mucosal involvement. Average number of involved mucous membranes was 2.83 ± 0.89. Average length of hospital stay was 10.30 ± 3.34 days. Length of hospital stay in recurrent cases was shorter than isolated cases (6.3 days vs. 10.17 days). Recurrence was observed in 21.7% of patients. The number of mucosal membranes involved was more in the first episode of recurrent cases than isolated cases (3.2 vs. 2.72). Of all patients, 47.8% were co-infected with pathogens apart from M. pneumoniae. Recurrence rate of the co-infection group was 36.4%.Conclusion: We report observations from the largest pediatric cohort with MIRM in China. Patients with younger age at onset had more severe skin and mucosal involvement, even similar to SJS/TEN. A higher recurrence rate and incidence of co-infections were observed in our cohort. The co-infection group had a higher recurrence rate, which further supports the concept of reactive infectious mucocutaneous eruption.Keywords
Funding Information
- Beijing Hospitals Authority (DFL20241201)
This publication has 18 references indexed in Scilit:
- Clinical and microbiological characteristics of reactive infectious mucocutaneous eruption: A case series of 5 patientsJAAD Case Reports, 2021
- Mucocutaneous manifestations in children hospitalized with COVID-19Journal of the American Academy of Dermatology, 2021
- Reactive infectious mucocutaneous eruption: Mycoplasma pneumoniae ‐induced rash and mucositis and other parainfectious eruptionsClinical and Experimental Dermatology, 2020
- Mycoplasma pneumoniae‐associated mucositis complicated by herpes simplex virus dissemination and Staphylococcus Epidermidis bacteremiaPediatric Dermatology, 2020
- Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired PneumoniaJAMA Dermatology, 2020
- Mucocutaneous Eruptions in Acutely Ill Pediatric Patients—Think of Mycoplasma pneumoniae (and Other Infections) FirstJAMA Dermatology, 2020
- Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae–Induced Rash and Mucositis ConceptPediatric Dermatology, 2017
- Characterization of Children With Recurrent Episodes of Stevens Johnson SyndromeJournal of the Pediatric Infectious Diseases Society, 2017
- Community-acquired pneumonia: An overviewPostgraduate Medicine, 2015
- Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic reviewJournal of the American Academy of Dermatology, 2015